Fiori Press Release
Contact:
Pat Rodden, Fiori
503.248.4764
Fiori Begins New Relationship with Bioject
PORTLAND, Ore. —
November 1, 2003 —
Fiori, a consumer research and design firm, announces a new relationship with Bioject, the world’s leading developer and manufacturer of needle-free injection systems. Fiori will work with Bioject’s marketing and product development teams, applying contextual research to study the end users of Bioject’s revolutionary injection systems.
Contextual Research
Fiori’s approach to consumer research is called contextual research. Contextual research is in-depth research examining people, practices and products in real world situations. It takes consumer research out focus groups and labs and into the places where people live, work, play and shop. It’s an approach rooted in anthropology, psychology and sociology and it provides a foundation for the development of products, services and messaging that connect with people.
About Fiori
Founded in 1994, Fiori is an award-winning contextual research and design company. Fiori applies a unique, context-driven approach, where the study of real people in the real world inspires and guides the development of products, services and communications. Fiori has two Pacific Northwest offices, with research and design in Portland, Oregon, and business development and operations management in Seattle, Washington. Fiori’s clients include the Fortune 500 and companies on their way there. Clients include Bioject, Dagger, Intel, HP, LSI Logic, Precor, Samsung and Yakima. Fiori has been recognized with over 20 international awards including awards from Business Week, Metropolis Magazine, Germany’s Red Dot, Japan’s Good Design, Chicago Athenaeum and CES Innovation. For more information, visit http://www.fioriinc.com.
About Bioject
Bioject Medical Technologies Inc., based in Bedminster, New Jersey, is an innovative developer and manufacturer of needle-free drug delivery systems. Needle-free injection works by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. The Company is focused on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies.
###